Biological activities of topical retinaldehyde

Dermatology

Volumn 199, Issue SUPPL. 1, 1999, Pages 19-24

  Didierjean, L ^a   Tran, C ^a   Sorg, O ^a   Saurat, Jean Hilarie ^a,b  

^a UNIVERSITY HOSPITAL   (Switzerland)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Biological activities; Citral; Mouse tail model; Myeloperoxidase; Retinaldehyde, 9 cis; Retinaldehyde, topical; Retinoid irritation

Indexed keywords

ALITRETINOIN; FILAGGRIN; KERATIN; LORICRIN; MESSENGER RNA; RETINAL; RETINOIC ACID; RETINOIC ACID BINDING PROTEIN;

ANIMAL EXPERIMENT; CELL PROLIFERATION; CONFERENCE PAPER; CONTROLLED STUDY; DNA SYNTHESIS; DRUG ACTIVITY; DRUG EFFECT; DRUG TOLERABILITY; EPIDERMIS; KERATOSIS; METAPLASIA; MOUSE; NONHUMAN; OXIDATION; PRIORITY JOURNAL; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; KERATINS; KERATOLYTIC AGENTS; MICE; MONOTERPENES; PEROXIDASE; RETINALDEHYDE; SKIN; TERPENES; TRETINOIN;

EID: 0032772740     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000051373     Document Type: Conference Paper

References (18)

1. Siegenthaler G, Saurat J-H: Therapy with synthetic retinoid (Ro 101670) etretin increases the cellular retinoic acid-binding protein in nonlesional psoriatic skin. J Invest Dermatol 1986; 87:122-124.
2. Hirschel Scholz S, Siegenthaler G, Saurat J-H: ligand-specific and non-specific in vivo modulation of human epidermal cellular retinoic acid binding protein (CRABP). Eur J Clin Invest 1989;19:220-227.
3. Elder JT, Aström A, Tavakkol A, Griffiths CEM, Krust A, Kastner P, Chambon P, Vorhees JJ: Differential regulation of retinoic acid receptors and binding proteins in human skin. J Invest Dermatol 1992;98:673-679.
4. Saurat J-H, Didierjean L, Masgrau E, Piletta PA, Jaconi S, Châtellard-Gruaz D, GumowskiSunek D, Masouyé I, Salomon D, Siegenthaler G: Topical retinaldehyde on human skin: Biologic effects and tolerance. J Invest Dermatol 1994;103:770-774.
5. Wrench R: Assessing drugs for psoriasiform diseases and their antiparakeratotic mechanisms using the mouse-tail test; in Maibach HI, Lowe NJ (eds): Models in Dermatology. Basel, Karger, 1985, vol 2, pp 76-91.
6. Schweizer J, Fürstenberger G, Winter H: Selective suppression of two postnatally acquired 70-kD and 65-kD keratin proteins during continuous treatment of adult mouse tail epidermis with vitamin A. J Invest Dermatol 1987;89: 125-137.
7. Schweizer J: Vitamin A mediated keratin expression in mouse tail epidermis; in Reichert U, Shroot B (eds): Pharmacology of Retinoids in the Skin. Pharmacol Skin. Basel, Karger, 1989, vol 3, pp 132-135.
8. Didierjean L, Wrench R, Saurat J-H: Expression of cytoplasmic antigens linked to orthokeratosis during the development of parakeratosis in newborn mouse tail epidermis. Differentiation 1983;23:250-255.
9. Connor MJ: Oxidation of retinol to retinoic acid as a requirement for biological activity in mouse epidermis. Cancer Res 1981;48:7038-7040.
10. Didierjean L, Carraux P, Grand D, Sass JO, Nau H, Saurat JH: Topical retinaldehyde increases skin content of retinoic acid and exerts biologic activity in mouse skin. J Invest Dermatol 1996; 107:714-719.
11. Fischer GJ, Talwar HS, Xiao JH, Datta SC, Reddy AP, Gaub MP, Rochetteegly C, Chambon P, Vorrhees JJ: Immunological identification and functional quantitation of retinoic acid and retinoid X receptor proteins in human skin. J Biol Chem 1994;269:20629-20635.
12. Sorg O, Didierjean L, Saurat J-H: Metabolism of topical retinaldehyde. Dermatology 1999; 199(suppl 1):13-17.
13. Didierjean L, Sass JO, Carraux P, Grand D, Sorg O, Plum C, Nau H, Saurat J-H: Topical 9-cis-retinaldehyde for delivery of 9-cis-retinoic acid in mouse skin. Exp Dermatol, in press.
14. Chen S, Ostrowski J, Whiting G, Roalsvig T, Hammer L, Currier SJ, Honeyman J, Knasniewski B, Yu KL, Sterzycki R, Kim, CU, Starret J, Mansuri M, Reczeck PR: Retinoic acid receptor gamma mediates topical retinoid efficacy and irritation in animal models. J Invest Dermatol 1995;104:779-783.
15. Fisher GJ, Esmann J, Griffiths CEM, Talwar HS, Duell EA, Hammerberg C, Elder JT, Karabin GD, Nickoloff BJ, Cooper KD, Voorhees JJ: Cellular, immunologic and biochemical characterization of topical retinoic acid-treated human skin. J Invest Dermatol 1991;96:699-707.
16. Sachsenberg-Studer EM: Tolerance of topical retinaldehyde in humans. Dermatology 1999; 199(suppl 1):61-63.
17. Bradley PP, Priebat DA, Christensen RD, Rothstein G: Measurement of cutaneous inflammation: Estimation of neutrophil content with an enzyme marker. J Invest Dermatol 1982;78: 206-209.
18. Châtellard-Gruaz D, Randolph RK, Hagens G, Saurat J-H, Siegenthaler G: Differentiation of human keratinocytes is accompanied by increased expression of CRABP-II and increased cellular concentration of retinoic acids: Retention of newly synthesized retinoic acids by CRABP-II. J Lipid Res 1998;39:1421-1429.